Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

Mama's Creations Q1 Earnings Call Highlights

Mama's Creations (NASDAQ:MAMA) reported sharply higher first-quarter fiscal 2027 results, with management pointing to new retail placements, the Crown I acquisition and broader customer growth as the main drivers, even as gross margins were pressured by launch-related costs. Chairman and CEO Adam L

MarketBeat

Gloo Q1 Earnings Call Highlights

Gloo (NASDAQ:GLOO) reported fiscal first-quarter revenue and adjusted EBITDA ahead of its own guidance and Wall Street consensus, as executives pointed to momentum from large strategic customers, recent acquisitions and growing demand for AI-enabled technology and marketing tools across faith-based

MarketBeat

Mission Produce Q2 Earnings Call Highlights

Mission Produce (NASDAQ:AVO) said its fiscal second quarter was pressured by an unusually high-supply avocado market, particularly from Mexico, which drove prices to multi-year lows and compressed margins despite higher avocado volumes. President and Chief Executive Officer John Pawlowski, who form

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Motorcar Parts of America Q4 Earnings Call Highlights

Motorcar Parts of America (NASDAQ:MPAA) reported stronger fiscal fourth-quarter and full-year results, with management pointing to sales momentum, new business commitments and improving profitability as key drivers heading into fiscal 2027. Chairman, President and Chief Executive Officer Selwyn Jof

MarketBeat

Amprius Insiders Are Selling: Should Investors Be Worried?

Amprius Technology is on track to set a new all-time high later this year after it reports Q2 results and guidance. Short interest suggests a squeeze is possible.

MarketBeat

Graham Q4 Earnings Call Highlights

Graham (NYSE:GHM) reported record fiscal 2026 revenue, orders and backlog, with management pointing to strong demand in defense, improving momentum in space and contributions from recent acquisitions as the company enters fiscal 2027. On the company’s fiscal fourth-quarter earnings call, President

MarketBeat

Assembly Biosciences Teases Gilead HSV-2 Decision, Liver Disease Data Ahead

Assembly Biosciences (NASDAQ:ASMB) outlined its antiviral and liver disease development strategy during a fireside chat at the 47th Annual Goldman Sachs Healthcare Conference, highlighting upcoming decisions tied to its herpes simplex virus type 2 program, expansion of its hepatitis delta candidate

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Optical Cable Q2 Earnings Call Highlights

Optical Cable (NASDAQ:OCC) reported sharply higher fiscal second-quarter sales and profit, with management citing strength in enterprise, data center and severe-duty markets, as well as improved manufacturing leverage. On the company’s fiscal 2026 second-quarter earnings call, President and Chief E

MarketBeat

FuelCell Energy Q2 Earnings Call Highlights

FuelCell Energy (NASDAQ:FCEL) reported a wider second-quarter loss for fiscal 2026 as a non-cash impairment tied to its Groton Navy project weighed on results, while management emphasized a sharply expanding sales pipeline tied largely to data center and artificial intelligence-related power demand.

MarketBeat

Duluth Q1 Earnings Call Highlights

Duluth (NASDAQ:DLTH) reported a narrower first-quarter loss and higher gross margins as management said its ongoing effort to reduce promotions, rationalize inventory and cut costs continued to reshape the apparel retailer’s financial profile. President and Chief Executive Officer Stephanie Puglies

MarketBeat

VinFast Auto Q1 Earnings Call Highlights

VinFast Auto (NASDAQ:VFS) reported sharply higher first-quarter 2026 vehicle deliveries and revenue, while management said gross margin was pressured by accounting impacts tied to an expanded free-charging program and other adjustments. On the company’s earnings call, Chairman Pham Nhat Quan Anh sa

MarketBeat

Gamehaus Q3 Earnings Call Highlights

Gamehaus (NASDAQ:GMHS) reported third-quarter fiscal 2026 revenue above its prior guidance range while management emphasized improving profitability, tighter marketing discipline and growing use of direct-to-consumer payments and artificial intelligence across the business. On the company’s earning

MarketBeat

What's Make of Macy's: Berkshire Hathaway's Latest Buy

Berkshire Hathaway just turned over a rock that many would not think to look under. See the status of its latest portfolio addition, retail giant Macy's.

MarketBeat

Compass Therapeutics Eyes FDA Path After Tovecimig Trial Win

Compass Therapeutics (NASDAQ:CMPX) Chief Executive Officer Tom Schuetz said the company is preparing for a key U.S. Food and Drug Administration meeting on tovecimig, its DLL4/VEGF bispecific antibody, after a randomized study in advanced biliary tract cancer met its primary endpoint and a key secon

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Campbell's Q3 Earnings Call Highlights

Campbell's (NASDAQ:CPB) executives used the company’s third-quarter fiscal 2026 earnings question-and-answer session to outline a more cautious operating backdrop heading into fiscal 2027, citing potential incremental inflation tied to higher oil prices, continued pressure in snacks and a focus on b

MarketBeat

AstroNova Q1 Earnings Call Highlights

AstroNova (NASDAQ:ALOT) reported higher fiscal first-quarter revenue and improved profitability, driven primarily by strength in its Aerospace segment, as management said the company is benefiting from commercial aircraft demand, growing orders and internal cost controls. On the company’s fiscal 20

MarketBeat

BASF Bets on China Growth as Zhanjiang Site Targets €5 Billion in Sales by 2030

Basf (ETR:BAS) executives said the company’s new Zhanjiang Verbund site in Guangdong province has started operations successfully, positioning the German chemicals group for further growth in China while adding a major new production platform built around digitalization, feedstock flexibility and re

MarketBeat

CME Group CEO Blasts Bitcoin Perpetual Futures, Warns of ‘2007’ Risk

CME Group (NASDAQ:CME) Chairman and CEO Terry Duffy sharply criticized the Commodity Futures Trading Commission’s approval of a Bitcoin perpetual futures contract for Kalshi, saying the product does not fit his view of a futures contract and raises risks for retail investors. Speaking at an investo

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Chime Financial CEO Maps Growth Roadmap, $2.7B Revenue Target at Conference

Chime Financial (NASDAQ:CHYM) founder and CEO Chris Britt outlined the digital banking company’s growth strategy, product roadmap and margin targets during a presentation at the William Blair conference, emphasizing Chime’s focus on primary checking relationships and mainstream U.S. consumers. Brit

MarketBeat

CG Oncology Touts Cretostimogene Data, BLA Progress in Bladder Cancer Push

CG Oncology (NASDAQ:CGON) is focused on advancing cretostimogene, an oncolytic immunotherapy for non-muscle invasive bladder cancer, Chief Executive Officer Arthur Kuan said during a discussion at the Jefferies Global Healthcare Conference in New York. Kuan said the company believes the therapy cou

MarketBeat

Certara Outlines AI Push, Cost Cuts and New Growth Engines at Jefferies Conference

Certara (NASDAQ:CERT) executives outlined the company’s strategic realignment, artificial intelligence initiatives and cost priorities during a discussion at Jefferies’ 2026 Global Healthcare Conference, with newly appointed Chief Executive Officer Jon Resnick saying the company is focused on creati

MarketBeat

Celsius Plots Energy Drink Comeback as Alani, Rockstar Deals Reshape Growth

Celsius (NASDAQ:CELH) executives said the company is working through a major portfolio transition as it integrates Alani and Rockstar into its platform while repositioning the core Celsius brand for renewed growth. Speaking at an investor conference, Chairman and CEO John Fieldly described the comp

MarketBeat

Petco Faces Tough Competition, But Momentum Is Building

Petco Health and Wellness is becoming a comprehensive petcare services destination capable of competing with Chewy for market share.

MarketBeat

CareDx Highlights 39% Q1 Growth, Naveris Oncology Push at Jefferies

CareDx (NASDAQ:CDNA) executives outlined the company’s growth strategy, first-quarter performance and pipeline priorities during a presentation at the Jefferies Healthcare Conference, emphasizing transplant diagnostics, specialty oncology and digital workflow integration. John Hanna, chief executiv

MarketBeat

Bruker Signals Growth Pivot as Semiconductor and Overseas Orders Gain Steam

Bruker (NASDAQ:BRKR) is seeing stronger order momentum across several end markets, with semiconductor metrology, non-U.S. academic and government customers, and parts of its diagnostics business helping offset continued weakness in U.S. academic funding, a company representative said at a Jefferies

1 … 7 8 9 10

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.